Ro, a US-based online healthcare services provider backed by publisher Forbes, has collected $200m in a funding round led by General Catalyst, CNBC reported yesterday.
Founded in 2017, Ro’s initial offering was Roman, a telehealth service focused on male conditions that often have a stigma attached to them, such as erectile dysfunction. It has since adjusted its focus to include chronic conditions that require ongoing support, such as diabetes.
The company has also added a similar service aimed at women, Rory, and one specifically aimed at helping users to quit smoking, Zero. Its newest offering is Ro Pharmacy, which delivers generic drugs at a flat fee of $5 each.
Ro also operates a health information portal called Health Guides, using it as a marketing tool for its services.
The money will allow Ro to hire additional full-time doctors and nurses. The company is also exploring adding at-home diagnostic testing services.
Ro raised $85m in series B funding from unnamed investors at a $500m valuation in April 2019, according to TechCrunch.
FirstMark Capital led an $88m series A round in mid-2018, with participation from Initialized Capital, General Catalyst, Slow Ventures, Sinai Ventures, Tusk Ventures, Torch Capital, BoxGroup and assorted angel investors.
Forbes participated in a $3.1m seed round in 2017 that was led by General Catalyst and also featured Initialized Capital, BoxGroup, Slow Ventures and several angel investors.
